definiens: means the twelve ( 12 ) month hydrogel implant containing fifty [ * * * ] of Compound as the active pharmaceutical ingredient an d the related Insertion Tool referenced in the NDA a nd sold as of the Date of Agreement in the United S tates under the trademark VANTAS ® and as referenced in the Marketing Authorization fo r VANTAS ® in Europe, as it stands following the Mutual Recognition Procedure [ * * * ], including ( a ) all modified or improved versions o f VANTAS ® that would improve the safety or effectiven ess of VANTAS ® for use in the Initial Indication ; and ( b ) any other product that the Parties agree, pursuant to the terms and conditions of Section 3, shall be a Licensed Product . Notwithstan ding any provision of this Agreement, in no event shall Licensed Product include or be deemed t o include the product known as Supprelin ® -LA or any adaptations, modifications, line extensio ns or other improvements thereto